Clinical trial
Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Glucosamine Supplements
NCT07843342 is registered in ClinicalTrials.gov with TCI Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Glucosamine Supplements
- Lead sponsor
- TCI Co., Ltd.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 21, 2026
- Completion date
- January 29, 2027
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glucosamine, liposomal encapsulation